Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...

We provide broad, well-rounded studies in the arts, sciences, humanities and social sciences, emphasizing experiential learning and faculty-mentored research in a global, diverse and inclusive ...